EA201391655A1 - Производные пиразола в качестве ингибиторов альдостеронсинтазы - Google Patents

Производные пиразола в качестве ингибиторов альдостеронсинтазы

Info

Publication number
EA201391655A1
EA201391655A1 EA201391655A EA201391655A EA201391655A1 EA 201391655 A1 EA201391655 A1 EA 201391655A1 EA 201391655 A EA201391655 A EA 201391655A EA 201391655 A EA201391655 A EA 201391655A EA 201391655 A1 EA201391655 A1 EA 201391655A1
Authority
EA
Eurasian Patent Office
Prior art keywords
aldosteron
pyrazol
derivatives
synthase inhibitors
methods
Prior art date
Application number
EA201391655A
Other languages
English (en)
Russian (ru)
Inventor
Майкл Грегори Белл
Пол Дж. Хугерстраат
Томас Эдвард Мабри
Кванронг Шен
Ана Мария Эскрибано
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201391655(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA201391655A1 publication Critical patent/EA201391655A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EA201391655A 2011-06-14 2012-06-07 Производные пиразола в качестве ингибиторов альдостеронсинтазы EA201391655A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161496657P 2011-06-14 2011-06-14
US201161506349P 2011-07-11 2011-07-11
PCT/US2012/041212 WO2012173849A1 (en) 2011-06-14 2012-06-07 Pyrazole derivatives useful as aldosterone synthase inhibitors

Publications (1)

Publication Number Publication Date
EA201391655A1 true EA201391655A1 (ru) 2014-07-30

Family

ID=46317515

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201391655A EA201391655A1 (ru) 2011-06-14 2012-06-07 Производные пиразола в качестве ингибиторов альдостеронсинтазы

Country Status (33)

Country Link
US (1) US8778984B2 (enExample)
EP (1) EP2721009B1 (enExample)
JP (1) JP5890012B2 (enExample)
KR (1) KR101555119B1 (enExample)
CN (1) CN103596930B (enExample)
AR (1) AR086665A1 (enExample)
AU (1) AU2012271023A1 (enExample)
BR (1) BR112013031873A2 (enExample)
CA (1) CA2836804C (enExample)
CL (1) CL2013003536A1 (enExample)
CO (1) CO6821955A2 (enExample)
CR (1) CR20130601A (enExample)
CY (1) CY1116687T1 (enExample)
DK (1) DK2721009T3 (enExample)
DO (1) DOP2013000284A (enExample)
EA (1) EA201391655A1 (enExample)
EC (1) ECSP13013080A (enExample)
ES (1) ES2548210T3 (enExample)
GT (1) GT201300307A (enExample)
HR (1) HRP20150939T1 (enExample)
HU (1) HUE026461T2 (enExample)
IL (1) IL229485A0 (enExample)
ME (1) ME02223B (enExample)
MX (1) MX336042B (enExample)
PE (1) PE20140606A1 (enExample)
PH (1) PH12013502597A1 (enExample)
PL (1) PL2721009T3 (enExample)
PT (1) PT2721009E (enExample)
RS (1) RS54269B1 (enExample)
SG (1) SG194822A1 (enExample)
SI (1) SI2721009T1 (enExample)
TW (1) TWI518073B (enExample)
WO (1) WO2012173849A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170253577A1 (en) 2014-07-04 2017-09-07 Japan Tobacco Inc. Method for producing indole compound
CN108586221B (zh) * 2018-06-26 2021-03-02 常州制药厂有限公司 用于制备替卡格雷的中间体及其制备方法
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165369A (en) * 1981-04-06 1982-10-12 Teijin Ltd Pyrazole derivative and its preparation
US4617307A (en) 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5057521A (en) 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
JPWO2007111175A1 (ja) 2006-03-17 2009-08-13 日本碍子株式会社 目封止ハニカム構造体の製造方法
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
CN102711916B (zh) 2010-01-14 2015-09-02 诺华股份有限公司 肾上腺激素调节剂的用途

Also Published As

Publication number Publication date
CA2836804A1 (en) 2012-12-20
AU2012271023A1 (en) 2013-11-28
ME02223B (me) 2016-02-20
MX2013014790A (es) 2014-01-24
EP2721009A1 (en) 2014-04-23
BR112013031873A2 (pt) 2016-12-13
KR20140009564A (ko) 2014-01-22
CL2013003536A1 (es) 2014-07-11
WO2012173849A1 (en) 2012-12-20
EP2721009B1 (en) 2015-08-12
PL2721009T3 (pl) 2016-01-29
KR101555119B1 (ko) 2015-09-22
CR20130601A (es) 2014-05-02
CN103596930B (zh) 2015-05-13
PH12013502597A1 (en) 2018-04-11
TW201311647A (zh) 2013-03-16
ES2548210T3 (es) 2015-10-14
JP2014517034A (ja) 2014-07-17
PT2721009E (pt) 2015-10-23
HUE026461T2 (en) 2016-05-30
DOP2013000284A (es) 2014-06-30
JP5890012B2 (ja) 2016-03-22
RS54269B1 (sr) 2016-02-29
PE20140606A1 (es) 2014-05-17
DK2721009T3 (en) 2015-10-26
CN103596930A (zh) 2014-02-19
CA2836804C (en) 2016-05-24
NZ617642A (en) 2015-11-27
HRP20150939T1 (xx) 2015-10-09
ECSP13013080A (es) 2014-01-31
MX336042B (es) 2016-01-07
TWI518073B (zh) 2016-01-21
SG194822A1 (en) 2013-12-30
CO6821955A2 (es) 2013-12-31
CY1116687T1 (el) 2017-03-15
GT201300307A (es) 2014-11-24
US8778984B2 (en) 2014-07-15
US20120322841A1 (en) 2012-12-20
HK1193103A1 (en) 2014-09-12
IL229485A0 (en) 2014-01-30
AR086665A1 (es) 2014-01-15
SI2721009T1 (sl) 2015-10-30

Similar Documents

Publication Publication Date Title
EA201400412A1 (ru) ЗАМЕЩЕННЫЕ БЕНЗИЛИНДАЗОЛЫ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Bub1 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
EA201491012A1 (ru) Гетероциклические ингибиторы глютаминазы
EA201270149A1 (ru) Ингибиторы bace
ECSP15043696A (es) Compuestos de heteroarilo y sus usos
AU2012213775A8 (en) 7-azaindole derivatives
EA201590224A1 (ru) Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы
MX373392B (es) Nuevos derivados de quinolona.
EA201791717A1 (ru) Стабильные водные составы адалимумаба
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
EA201590281A1 (ru) Новые гетероарильные и гетероциклические соединения, их композиции и способы
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
EA201490912A1 (ru) Производные [1,2,3]триазоло[4,5-d]пиримидина в качестве агонистов каннабиноидного рецептора 2
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
EA201491376A1 (ru) Производные 1h-пирроло[2,3-b]пиридина и их применение в качестве ингибиторов киназы
UA111198C2 (uk) Похідні 1-феніл-2-піридинілалкільних спиртів як інгібітори фосфодіестерази
EA201491149A1 (ru) Пиразолопиридиновые производные, способы их получения и их терапевтическое применение
EA201500628A1 (ru) Индолкарбоксамидные производные в качестве антагонистов p2xрецепторов
EA201590552A1 (ru) Аминохинолины в качестве ингибиторов киназы
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
ZA201306416B (en) Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
CY1118079T1 (el) Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης
CR20120502A (es) Uso de nuevos inhibidores de pan-cdk para tratar tumores